IP Library Granted Patent US 7,553,655
Granted Patent B2
US 7,553,655 · App. 11/929,079 · Granted Jun 30, 2009

Bacterial host cell for the direct expression of peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,655
App. No.
11/929,079
Granted
Jun 30, 2009
Kind
B2
Abstract

Expression systems are disclosed for the direct expression of peptide products into the culture media where genetically engineered host cells are grown. High yield was achieved with a special selection of hosts, and/or fermentation processes which include careful control of cell growth rate, and use of an inducer during growth phase. Special universal cloning vectors are provided for the preparation of expression vectors which include control regions having multiple promoters linked operably with coding regions encoding a signal peptide upstream from a coding region encoding the peptide of interest. Multiple transcription cassettes are also used to increase yield. The production of amidated peptides using the expression systems is also disclosed.

Claims (1)

1. A recombinant cell line UGL820 having ATCC Accession Number PTA-5569.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
SECURITY INTEREST Recorded Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
RELEASE OF SECURITY INTEREST Recorded Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES INC.
Reel/Frame 047739/0437 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED ON REEL 039184 FRAME 0797. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 02/01/2016. Recorded Aug 15, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039682/0212 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
SECURITY AGREEMENT Recorded Oct 3, 2008
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 021630/0352 →